Graeme Boocock is a Patent Agent in the Ottawa office of Borden Ladner Gervais LLP. He specializes in drafting and prosecution of patent applications in the life sciences, including personalized medicine and antibody technologies. Graeme counsels clients on patenting strategies and assists with management of international portfolios.
Graeme also assists clients with Plant Breeders' Rights applications. He is an amateur plant breeder and recently developed the new Passiflora variety 'Pole Star'.
Graeme conducted his doctoral research at The Hospital for Sick Children (University of Toronto) and this culminated in the discovery of the human gene that is mutated in Shwachman-Diamond syndrome – an inherited disease involving bone marrow failure, leukemia risk, pancreatic exocrine insufficiency, and varied developmental problems. Graeme then worked for three years as a postdoctoral researcher at the MRC Laboratory of Molecular Biology in Cambridge, UK, focusing on synthetic biology and protein engineering.